Individual dopaminergic neurons show raised iron levels in Parkinson disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

Mitochondrial DNA mutations in human disease

Taylor, R. W., & Turnbull, D. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1606 · Cited by 1,866 · see citing works

The ubiquitin pathway in Parkinson's disease

Leroy, E., Boyer, R., Auburger, G. W. J., Leube, B., Ulm, G., Mezey, É., Harta, G., Brownstein, M., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,572 · see citing works

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · see citing works

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · see citing works

Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein

Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103 · see citing works

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome

Zhou, B., Westaway, S. K., Levinson, B., Johnson, M., Gitschier, J. M., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 756 · see citing works

Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz Syndrome

Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M., Ching, K. H. L., & Gitschier, J. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020817 · Cited by 713 · see citing works

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

Gibb, W. R. G., & Lees, A. J. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574 · see citing works

The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity

Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 544 · see citing works

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537 · see citing works

A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe

Abbas, N., Lücking, C. B., Ricard, S., Dürr, A., Bonifati, V., Michele, G. D., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 529 · see citing works

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

Sofic, E., Paulus, W., Jellinger, K. A., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 523 · see citing works

Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice

LaVaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., et al. (2001) · Nature Genetics · doi:10.1038/84859 · Cited by 509 · see citing works

Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.

Meyron‐Holtz, E. G., Ghosh, M. C., Iwai, K., LaVaute, T., Brazzolotto, X., Berger, U. V., Land, W., Ollivierre‐Wilson, H., Grinberg, A., Love, P., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600041 · Cited by 408 · see citing works

The Relevance of Iron in the Pathogenesis of Parkinson's Disease

Götz, M. E., Double, K. L., Gerlach, M., Youdim, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342 · see citing works

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · see citing works

Über den eisennachweis im gehirn, besonders in zentren des extrapyramidal-motorischen systems. I. Teil

Spatz, H. (1922) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02865844 · Cited by 252 · see citing works

Iron in the basal ganglia in Parkinson's disease

Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229 · see citing works

Histochemical Distribution of Non-Haem Iron in the Human Brain

Morris, C. M., Candy, J., Oakley, A. E., Bloxham, C. A., & Edwardson, J. A. (1992) · Cells Tissues Organs · doi:10.1159/000147312 · Cited by 218 · see citing works

α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro

Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 181 · see citing works

Isoforms of ferritin have a specific cellular distribution in the brain

Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179 · see citing works

T 2 relaxation time in patients with Parkinson's disease

Antonini, A., Leenders, K. L., Meier, D., Oertel, W. H., Boesiger, P., & Anliker, M. (1993) · Neurology · doi:10.1212/wnl.43.4.697 · Cited by 168 · see citing works

Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting

Song, D. D., & Haber, S. N. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05102.2000 · Cited by 163 · see citing works

Aggregation and neurotoxicity of α-synuclein and related peptides

EI-Agnaf, O. M. A., & Irvine, G. B. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300559 · Cited by 151 · see citing works

Differential localization of α-, β- and γ-synucleins in the rat CNS

Li, J.-Y., Jensen, P. H., & Dahlström, A. B. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00143-4 · Cited by 141 · see citing works

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease

Mezey, É., Dehejia, A. M., Harta, G., Suchy, S. F., Nussbaum, R. L., Brownstein, M. J., & Polymeropoulos, M. H. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000446 · Cited by 137 · see citing works

In situ characterization and mapping of iron compounds in Alzheimer's disease tissue

Collingwood, J. F., Mikhaylova, A., Davidson, M., Batich, C. D., Streit, W. J., Terry, J., & Dobson, J. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7401 · Cited by 104 · see citing works

Iron histochemistry of the substantia nigra in Parkinson's disease.

Morris, C. M., & Edwardson, J. A. (1994) · PubMed · Cited by 70 · see citing works

Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra

Gałązka-Friedman, J., Bauminger, E. R., Koziorowski, D., & Friedman, A. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.11.005 · Cited by 49 · see citing works

Iron in the Parkinsonian substantia nigra.

Gerlach, M., Double, K. L., Riederer, P. F., Hirsch, É. C., Jellinger, K. A., Jenner, P. G., TRAUTWEIN, A. X., & Youdim, M. B. H. (1997) · PubMed · Cited by 34 · see citing works

Effect of seedling age and water depth on morphological and physiological aspects of transplanted rice under high temperature

Khakwani, A. A., Shiraishi, M., Zubair, M., Baloch, M. S., Naveed, K., & Awan, I. (2005) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2005.b0389 · Cited by 28 · see citing works

Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset

Gnanalingham, K. K., Milkowski, N. A., Smith, L. A., Hunter, A. J., Jenner, P. G., & MARSDEN, C. D. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00086-z · Cited by 26 · see citing works

Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates.

Youdim, M. B. H., Ashkenazi, R., Ben‐Shachar, D., & Yehuda, S. (1984) · PubMed · Cited by 24 · see citing works

Brain transferrin receptors and the distribution of cytochrome oxidase

Morris, C. M., Candy, J., Bloxham, C. A., & Edwardson, J. A. (1990) · Biochemical Society Transactions · doi:10.1042/bst0180647 · Cited by 12 · see citing works

The role of oxidative stress in neurodegenerative diseases

Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · see citing works

Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives

Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S., et al. (2022) · Cells · doi:10.3390/cells11030552 · Cited by 915 · see citing works

Quantitative susceptibility mapping (QSM): Decoding <scp>MRI</scp> data for a tissue magnetic biomarker

Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878 · see citing works

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., Wong, B. X. W., Adlard, P. A., Cherny, R. A., Lam, L. Q., et al. (2012) · Nature Medicine · doi:10.1038/nm.2613 · Cited by 594 · see citing works

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · see citing works

Intracellular iron transport and storage: from molecular mechanisms to health implications

Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526 · see citing works

Biological metals and metal-targeting compounds in major neurodegenerative diseases

Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · see citing works

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works

The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases

Cannon, J. R., & Greenamyre, J. T. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr239 · Cited by 462 · see citing works

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease

Martín‐Bastida, A., Ward, R. J., Newbould, R. D., Piccini, P. P., Sharp, D. J., Kabba, C., Patel, M. C., Spino, M., Connelly, J., Tricta, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01402-2 · Cited by 382 · see citing works

Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration

Ryan, S. K., Zelic, M., Han, Y., Teeple, E. A., Chen, L., Sadeghi, M., Shankara, S., Guo, L., Li, C., Pontarelli, F., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01221-3 · Cited by 368 · see citing works

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361 · see citing works

Emerging therapies in Parkinson disease — repurposed drugs and new approaches

Elkouzi, A., Vedam‐Mai, V., Eisinger, R. S., & Okun, M. S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0155-7 · Cited by 304 · see citing works

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease

Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264 · see citing works

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

Chen, L., Shen, Q.-Q., Liu, Y.-J., Zhang, Y., Sun, L., Ma, X.-Z., Song, N., & Xie, J.-X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02071-0 · Cited by 261 · see citing works

The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases

Dušek, P., Roos, P. M., Litwin, T., Schneider, S. A., Flaten, T. P., & Aaseth, J. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.007 · Cited by 253 · see citing works

Brain iron metabolism and its perturbation in neurological diseases

Crichton, R. R., Dexter, D. T., & Ward, R. J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 246 · see citing works

The transition metals copper and iron in neurodegenerative diseases

Rivera-Mancía, S., Pérez‐Neri, I., Rı́os, C., Tristán-López, L. A., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 243 · see citing works

Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers

Kostka, M., Högen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709634200 · Cited by 230 · see citing works

Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases

Zhou, Z., & Tan, E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0218-4 · Cited by 229 · see citing works

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease

Lotfipour, A. K., Wharton, S., Schwarz, S. T., Gontu, V. K., Schäfer, A., Peters, A. M., Bowtell, R. W., Auer, D. P., Gowland, P. A., & Bajaj, N. P. S. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22752 · Cited by 210 · see citing works

Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities

Singh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 205 · see citing works

The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease

Acosta‐Cabronero, J., Cárdenas‐Blanco, A., Betts, M. J., Butryn, M., Valdés-Herrera, J. P., Galazky, I., & Nestor, P. J. (2016) · Brain · doi:10.1093/brain/aww278 · Cited by 199 · see citing works

Crosstalk Between Calcium and Redox Signaling: From Molecular Mechanisms to Health Implications

Hidalgo, C., & Donoso, P. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1886 · Cited by 197 · see citing works

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

Mastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195 · see citing works

Mitochondrial iron metabolism and its role in neurodegeneration

Horowitz, M. P., & Greenamyre, J. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100354 · Cited by 195 · see citing works

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease

Ferrer, I., Martinez, A., Blanco, R. E., Dalfó, E., & Carmona, M. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0482-8 · Cited by 190 · see citing works

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 190 · see citing works

Brain Iron Metabolism Dysfunction in Parkinson’s Disease

Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 183 · see citing works

Mitochondrial Dysfunction in Parkinson's Disease

Keane, P. C., Kurzawa‐Akanbi, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson s Disease · doi:10.4061/2011/716871 · Cited by 177 · see citing works

Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death

Bossers, K., Meerhoff, G. F., Balesar, R. A., van Dongen, J. W., Kruse, C. G., Swaab, D. F., & Verhaagen, J. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00171.x · Cited by 173 · see citing works

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

Du, G., Liu, T., Lewis, M. M., Kong, L., Wang, Y., Connor, J. R., Mailman, R. B., & Huang, X. (2015) · Movement Disorders · doi:10.1002/mds.26417 · Cited by 167 · see citing works

Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration

Finazzi, D., & Arosio, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1329-0 · Cited by 166 · see citing works

Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration

Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 161 · see citing works

Cerebral Iron Deposition in Neurodegeneration

Dušek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159 · see citing works

Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study

Zhang, J., Zhang, Y., Wang, J., Cai, P., Luo, C., Qian, Z., Dai, Y., & Feng, H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.036 · Cited by 158 · see citing works

The Effects of Polyphenols on Survival and Locomotor Activity in Drosophila melanogaster Exposed to Iron and Paraquat

Jiménez-Del-Río, M., Guzman‐Martínez, C., & Velez‐Pardo, C. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0046-1 · Cited by 151 · see citing works

Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons

Wang, J., Song, N., Jiang, H., Wang, J., & Xie, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.021 · Cited by 150 · see citing works

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

Rogers, J. T., Bush, A. I., Cho, H.-H., Smith, D. H., Thomson, A. M., Friedlich, A. L., Lahiri, D. K., Leedman, P. J., Huang, X., & Cahill, C. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361282 · Cited by 148 · see citing works

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage

Farr, A. C., & Xiong, M. P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 151 · see citing works

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease

Šimunović, F., Yi, M., Wang, Y., Stephens, R. M., & Sonntag, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 141 · see citing works

Association between Heavy Metal Exposure and Parkinson’s Disease: A Review of the Mechanisms Related to Oxidative Stress

Pyatha, S., Kim, H., Lee, D., & Kim, K. (2022) · Antioxidants · doi:10.3390/antiox11122467 · Cited by 140 · see citing works

Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson’s disease

Tuon, T., Valvassori, S. S., Lopes-Borges, J., Luciano, T. F., Tromm, C. B., da Silva, L. A., Quevedo, J., de Souza, C. T., Lira, F. S., & Pinho, R. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.063 · Cited by 139 · see citing works

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Pan, Y., & Nicolazzo, J. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.009 · Cited by 131 · see citing works

Iron, the substantia nigra and related neurological disorders

Snyder, A. M., & Connor, J. R. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.005 · Cited by 137 · see citing works

Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice

Matak, P., Matak, A., Moustafa, S. M., Aryal, D. K., Benner, E. J., Wetsel, W. C., & Andrews, N. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519473113 · Cited by 133 · see citing works

Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of β-Amyloid Precursor Protein

Ayton, S., Lei, P., Hare, D. J., Duce, J. A., George, J. L., Adlard, P. A., McLean, C., Rogers, J. T., Cherny, R. A., Finkelstein, D. I., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3439-14.2015 · Cited by 131 · see citing works

Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention

Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C. V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3768-11.2011 · Cited by 125 · see citing works

Cathodoluminescence for the 21st century: Learning more from light

Coenen, T., & Haegel, N. M. (2017) · Applied Physics Reviews · doi:10.1063/1.4985767 · Cited by 124 · see citing works

Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?

Double, K. L., Reyes, S., Werry, E. L., & Halliday, G. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.001 · Cited by 123 · see citing works

Universality of protein reentrant condensation in solution induced by multivalent metal ions

Zhang, F., Weggler, S., Ziller, M. J., Ianeselli, L., Heck, B. S., Hildebrandt, A., Kohlbacher, O., Skoda, M. W. A., Jacobs, R. M. J., & Schreiber, F. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22852 · Cited by 123 · see citing works

Metal imaging in neurodegenerative diseases

Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 122 · see citing works

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

Jiang, H. F., Song, N., Xu, H., Zhang, S., Wang, J., & Xie, J. (2010) · Cell Research · doi:10.1038/cr.2010.20 · Cited by 122 · see citing works

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease

Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 120 · see citing works

Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells

Wu, Y., Li, X., Xie, W., Jankovic, J. J., Le, W., & Pan, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.008 · Cited by 115 · see citing works

Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping

Stüber, C., Pitt, D., & Wang, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010100 · Cited by 112 · see citing works

Novel targeted therapies for Parkinson’s disease

Ntetsika, T., Papathoma, P.-E., & Markaki, I. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00279-2 · Cited by 112 · see citing works

Recent Advances in Drug Therapy for Parkinson's Disease

Murakami, H., Shiraishi, T., Umehara, T., Omoto, S., & Iguchi, Y. (2022) · Internal Medicine · doi:10.2169/internalmedicine.8940-21 · Cited by 114 · see citing works

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease

Song, N., Wang, J., Jiang, H. F., & Xie, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.004 · Cited by 109 · see citing works

Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease

Isaya, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00029 · Cited by 109 · see citing works

Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases

Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 107 · see citing works

Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases

Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 107 · see citing works

Assessing Plasma Levels of Selenium, Copper, Iron and Zinc in Patients of Parkinson’s Disease

Hai-wen, Z., Lin, J., Wang, X., Cheng, X., Wang, J., Hu, B., Zhang, Y., Zhang, X., & Zhu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083060 · Cited by 105 · see citing works

The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease

Finkelstein, D. I., Billings, J. L., Adlard, P. A., Ayton, S., Sedjahtera, A., Masters, C. L., Wilkins, S., Shackleford, D. M., Charman, S. A., Bal, W., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0456-2 · Cited by 103 · see citing works

Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells

Perfeito, R., Lázaro, D. F., Outeiro, T. F., & Rego, A. C. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.08.002 · Cited by 102 · see citing works

Interactions between iron and α-synuclein pathology in Parkinson's disease

Chen, B., Wen, X., Jiang, H. F., Wang, J., Song, N., & Xie, J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.024 · Cited by 103 · see citing works

Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism

Bonilla-Ramírez, L., Jiménez-Del-Río, M., & Velez‐Pardo, C. (2011) · BioMetals · doi:10.1007/s10534-011-9463-0 · Cited by 98 · see citing works

The Relevance of Metals in the Pathophysiology of Neurodegeneration, Pathological Considerations

Jellinger, K. A. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00002-8 · Cited by 99 · see citing works

Iron–sulfur cluster biosynthesis and trafficking – impact on human disease conditions

Wachnowsky, C., Fidai, I., & Cowan, J. A. (2017) · Metallomics · doi:10.1039/c7mt00180k · Cited by 96 · see citing works

LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

Rocha, E. M., Miranda, B. R. D., Castro, S. L., Drolet, R. E., Hatcher, N. G., Yao, L., Smith, S. M., Keeney, M. T., Maio, R. D., Kofler, J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104626 · Cited by 96 · see citing works

Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders

Wise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D. L., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 95 · see citing works

Role of iron in neurotoxicity: a cause for concern in the elderly?

Stankiewicz, J., & Brass, S. D. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831ba07c · Cited by 94 · see citing works

Dietary Iron Intake and Risk of Parkinson's Disease

Logroscino, G., Gao, X., Chen, H., Wing, A., & Ascherio, A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn273 · Cited by 93 · see citing works

Molecular changes in the postmortem parkinsonian brain

Toulorge, D., Schapira, A. H. V., & Hajj, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13696 · Cited by 92 · see citing works

Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection

da Silva, V. K., de Freitas, B. S., da Silva Dornelles, A., Nery, L. R., Falavigna, L., Ferreira, R. D. P., Bogo, M. R., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8514-7 · Cited by 91 · see citing works

A Review on Lactoferrin and Central Nervous System Diseases

Li, Y.-Q., & Guo, C. (2021) · Cells · doi:10.3390/cells10071810 · Cited by 91 · see citing works

Can the emerging field of immunometabolism provide insights into neuroinflammation?

Lynch, M. (2019) · Progress in neurobiology · doi:10.1016/j.pneurobio.2019.101719 · Cited by 77 · see citing works

Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective

Yi, S., Wang, L.-F., Wang, H., Ho, M., & Zhang, S.-P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314753 · Cited by 66 · see citing works

Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping

Azuma, M., Hirai, T., Yamada, K., Yamashita, S., Ando, Y., Tateishi, M., Iryo, Y., Yoneda, T., Kitajima, M., Wang, Y., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4645 · Cited by 88 · see citing works

Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin

Rhodes, S. L., Buchanan, D. D., Ahmed, I., Taylor, K. D., Loriot, M., Sinsheimer, J. S., Bronstein, J. M., Elbaz, A., Mellick, G. D., Rotter, J. I., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.019 · Cited by 87 · see citing works

Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice

Guo, C., Hao, L.-J., Yang, Z., Chai, R., Zhang, S., Gu, Y., Gao, H., Zhong, M., Wang, T., Li, J., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.016 · Cited by 87 · see citing works

Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration

Dolatshahi, M., Hameghavandi, M. H. R., Sabahi, M., & Rostamkhani, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15242 · Cited by 85 · see citing works

Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses

Topiwala, A., Wang, C., Ebmeier, K. P., Burgess, S., Bell, S., Levey, D. F., Zhou, H., McCracken, C., Roca‐Fernández, A., Petersen, S. E., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004039 · Cited by 84 · see citing works

Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques

Carmona, A., Devès, G., & Ortega, R. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-1866-6 · Cited by 84 · see citing works

The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen

Rogers, J. T., Mikkilineni, S., Cantuti‐Castelvetri, I., Smith, D. H., Huang, X., Bandyopadhyay, S., Cahill, C. M., Maccecchini, M. L., Lahiri, D. K., & Greig, N. H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0513-5 · Cited by 81 · see citing works

Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications

Abdukarimov, N., Kokabi, K., & Kunz, J. (2025) · Antioxidants · doi:10.3390/antiox14050527 · Cited by 83 · see citing works

Oxidized DJ-1 as a possible biomarker of Parkinson’s disease

Saito, Y. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.13-108 · Cited by 83 · see citing works

Iron-dependent functions of mitochondria—relation to neurodegeneration

Gille, G., & Reichmann, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0503-7 · Cited by 77 · see citing works

Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis

Guo, J., Yue, F., Song, D., Bousset, L., Liang, X., Tang, J., Yuan, L., Li, W., Melki, R., Tang, Y. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03369-x · Cited by 74 · see citing works

Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis

Bandyopadhyay, S., & Rogers, J. T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.032 · Cited by 75 · see citing works

Nano-imaging of trace metals by synchrotron X-ray fluorescence into dopaminergic single cells and neurite-like processes

Carmona, A., Cloetens, P., Devès, G., Bohic, S., & Ortega, R. (2008) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b802242a · Cited by 74 · see citing works

Oxidative Stress Partially Contributes to Iron-Induced Alpha-Synuclein Aggregation in SK-N-SH Cells

Li, W., Jiang, H. F., Song, N., & Xie, J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9187-x · Cited by 72 · see citing works

Sequential Multiple-Target Sensor: In3+, Fe2+, and Fe3+ Discrimination by an Anthracene-Based Probe

Finelli, A., Chabert, V., Hérault, N., Crochet, A., Kim, C., & Fromm, K. M. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01478 · Cited by 71 · see citing works

Hinokitiol functions as a ferroptosis inhibitor to confer neuroprotection

Xi, J., Zhang, Z., Wang, Z., Wu, Q., He, Y., Xu, Y., Ding, Z., Zhao, H., Da, H., Zhang, F., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.011 · Cited by 69 · see citing works

Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease

Chege, P. M., & McColl, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00089 · Cited by 66 · see citing works

Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson’s disease

Friedrich, I., Reimann, K., Jankuhn, S., Kirilina, E. P., Stieler, J., Sonntag, M., Meijer, J., Weiskopf, N., Reinert, T., Arendt, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01145-2 · Cited by 67 · see citing works

Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano‐secondary ion mass spectrometry

Biesemeier, A., Eibl, O., Eswara, S., Audinot, J., Wirtz, T., Pezzoli, G., Zucca, F. A., Zecca, L., & Schraermeyer, U. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13648 · Cited by 67 · see citing works

Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model

Febbraro, F., Andersen, K. J., Sánchez-Guajardo, V., Tentillier, N., & Romero‐Ramos, M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.017 · Cited by 66 · see citing works

Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease

Weise, D., Lorenz, R., Schließer, M., Schirbel, A., Reiners, K., & Claßen, J. (2009) · Movement Disorders · doi:10.1002/mds.22665 · Cited by 64 · see citing works

α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson’s disease

Baksi, S., & Singh, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-12862-x · Cited by 64 · see citing works

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156 · see citing works

Iron Metabolism in Parkinson’s Disease

Gao, G., You, L., & Chang, Y. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00255 · Cited by 2 · see citing works

Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease

Lv, Z., Jiang, H. F., Xu, H., Song, N., & Xie, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0434-3 · Cited by 67 · see citing works

Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies

Ma, L., Azad, M. G., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 148 · see citing works

Iron histochemistry of the substantia nigra in Parkinson's disease.

Morris, C. M., & Edwardson, J. A. (1994) · PubMed · Cited by 70 · see citing works